BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 14, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2013
View Archived Issues
Dopamine D2 receptor PAMs for Parkinson's disease
Read More
Cancer Genetics launches FHACT test
Read More
US WorldMeds begins trial of Myobloc to treat sialorrhea
Read More
Collaboration to focus on 17-beta-HSD 1 inhibitor for endometriosis and estrogen-dependent cancers
Read More
RaQualia and Asahi Kasei Pharma sign joint research agreement
Read More
Phase III study of MLN-9702 for relapsed/refractory multiple myeloma opens to Japanese patients
Read More
Shionogi licenses pain products for Japan from Mundipharma
Read More
Recombinant tetravalent glycoprotein vaccine V-180 for dengue virus
Read More
Major role for rare heterozygous truncating mutations in autism etiology identified
Read More
Japanese researchers present novel peripheral blood lymphocyte-reducing agents
Read More
Carna Biosciences presents new BTK inhibitors
Read More
U.S. and Canadian team synthesizes novel PAR-4 antagonists for thromboembolism
Read More
Toleranzia discloses novel immunotolerizing fusion proteins for multiple sclerosis
Read More
Retrophin patents novel vitamin B5 prodrugs
Read More
Neuronascent Alzheimer's disease candidate advances to IND-enabling studies
Read More
AbbVie reports on first of six phase III studies of interferon-free, 12-week HCV regimen
Read More
Defibrotide receives European orphan drug designation for GVHD
Read More
Viriom expands licensing agreement with Roche for VM-1500
Read More
Clinical results for K-877, a novel PPAR-alpha receptor agonist, presented
Read More
Horizon Pharma to acquire U.S. rights to Vimovo
Read More
Consortium launches EPITARGET project focused on epileptogenesis and epilepsy
Read More
Project A.L.S. and Lilly team up on ALS research
Read More
Once-daily inhaled COPD agent launched in Japan
Read More
Topokine Therapeutics initiates phase II study of XAF-5 gel
Read More
Phase III SYNERGY trial of custirsen recommended to continue
Read More
European approval for Kadcyla
Read More